Monday, June 27, 2022 4:26:50 PM
What are you suggesting ?
Buy blue chips ?
Recent ACAD News
- Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 • Business Wire • 11/26/2024 09:05:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 11/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:30:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:43:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:41:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:40:08 AM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 11/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:48:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:14:26 PM
- Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview • Business Wire • 11/06/2024 09:05:00 PM
- Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million • Business Wire • 11/05/2024 09:05:00 PM
- Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024 • Business Wire • 10/17/2024 10:41:00 PM
- Acadia Pharmaceuticals annonce l’approbation de DAYBUE™ (trofinétide) par Santé Canada pour le traitement du syndrome de Rett • Business Wire • 10/16/2024 08:07:00 PM
- Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE™ (trofinetide) for the Treatment of Rett Syndrome • Business Wire • 10/16/2024 08:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 10:05:05 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/08/2024 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/26/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2024 10:53:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2024 10:46:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/23/2024 09:14:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:34:29 PM
- Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals • Business Wire • 09/23/2024 08:15:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 08/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:46:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:43:23 PM
Consumer Automotive Finance, Inc. Announces Cancellation of 200 Million Common Shares and Updates on Name and Ticker Symbol Change • CAFI • Dec 6, 2024 12:45 PM
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA • CATV • Dec 6, 2024 8:00 AM
Bantec's Howco Distributing Co. and Bantec Environmental Corp. Win Contracts • BANT • Dec 5, 2024 10:00 AM
Kona Gold Beverage, Inc. Announces Strategic Reorganization and a Bold New Direction • KGKG • Dec 5, 2024 9:33 AM
Branded Legacy, Inc. Strengthens Biotech Leadership, Focuses on Expansion, and Advances Strategic Rebranding • BLEG • Dec 5, 2024 8:30 AM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM